Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Altimmune

Start price
Target price
Perf. (%)
€20.50
07.09.22
€38.00
30.04.25
-77.51%
05.05.23

Could be very worthwhile Investment >20% year
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€69.37
07.09.22
€100.00
31.12.25
-12.07%
05.05.23

Could be very worthwhile Investment >20% year
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€285.85
07.09.22
€400.00
31.12.25
10.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€285.85
07.09.22
€400.00
31.12.25
10.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€285.85
07.09.22
€400.00
31.12.25
10.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€312.95
07.09.22
€450.00
31.12.25
24.24%
05.05.23

Could be very worthwhile Investment >20% year
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€74.46
07.09.22
€100.00
31.12.24
-29.49%
05.05.23

Could be very worthwhile Investment >20% year
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
29.17%
08.08.24

Could be very worthwhile Investment >20% year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€199.36
07.09.22
€300.00
31.12.24
36.69%
30.09.22

Could be very worthwhile Investment >20% year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€199.36
07.09.22
€300.00
31.12.24
36.69%
30.09.22

Could be very worthwhile Investment >20% year
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€199.36
07.09.22
€300.00
31.12.24
36.69%
30.09.22

Could be very worthwhile Investment >20% year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€208.80
07.09.22
€300.00
31.12.24
18.73%
08.08.24

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
2.68%
08.08.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€50.50
07.09.22
€80.00
31.12.24
-29.90%
05.05.23

Could be very worthwhile Investment >20% year
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.22
07.09.22
€100.00
31.12.25
73.41%
14.12.22

Could be very worthwhile Investment >20% year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
5.85%
31.07.24

Could be very worthwhile Investment >20% year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€0.81
07.09.22
€2.00
31.12.24
72.58%
09.12.22

Could be very worthwhile Investment >20% year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€9.70
07.09.22
€20.00
31.12.24
-76.29%
05.05.23

Could be very worthwhile Investment >20% year
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€7.44
07.09.22
€22.00
07.09.23
-99.03%
08.09.23

Could be very worthwhile Investment >20% year
buy
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€7.24
06.09.22
-
06.09.23
10.02%
17.09.22

Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
buy
ConocoPhillips

Start price
Target price
Perf. (%)
€111.44
06.09.22
€118.00
06.09.23
2.40%
07.09.23

Could be worthwhile Investment >10% per year
Denso Corp

Start price
Target price
Perf. (%)
€51.72
05.09.22
-
05.10.26
-68.02%
11.03.24

Probably not worthwhile Investment
Denso Corp

Start price
Target price
Perf. (%)
€51.72
05.09.22
-
05.10.26
-68.02%
11.03.24

Probably not worthwhile Investment
Denso Corp

Start price
Target price
Perf. (%)
€51.72
05.09.22
-
05.10.26
-68.02%
11.03.24

Probably not worthwhile Investment
Denso Corp

Start price
Target price
Perf. (%)
€51.72
05.09.22
-
05.10.26
-68.02%
11.03.24

Probably not worthwhile Investment